All not exited/Biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases
Adicet
All not exited/Clinical-stage biotech discovering and developing allogeneic gamma delta T cell therapies
Alebund
All not exited/Late clinical-stage Biopharmaceutical company discovering and developing therapies for the treatment of renal diseases and related chronic conditions
ARCELLX
All not exited/Clinical-stage biotech focusing on developing breakthrough CAR-T cell therapies
Avenzo
All not exited/Clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients
Centrexion
All not exited/Late clinical -stage biotech with one of the largest pipelines of novel, non-opioid therapies for chronic pain management
Crescendo Biologics
All not exited/UK clinical-stage biotech developing potent, multi-functional Humabody therapeutics
Design Therapeutics
All not exited/Clinical stage biotechnology company developing breakthrough therapies based on GeneTAC™ platform to address diseases caused by genetic expansion
Eluminex
All not exited/Clinical-stage biotechnology company focusing on innovative therapeutics in ophthalmic diseases
iCarbonX
All not exited/Leading Chinese technology platform focusing on life science
Innoforce
All not exited/Building a comprehensive biotech eco-system based on its world-class R&D and CDMO capabilities
Interius
All not exited/Preclinical stage biotech company developing a paradigm-shifting platform for cell-specific in vivo gene delivery
Kira Pharmaceuticals
All not exited/Clinical-stage biotech discovering breakthrough therapies for complement-mediated diseases
MEDx Translational Medicine Co., Ltd.
All not exited/Precision medicine leader in China offering integrated solutions of biomarkers, companion diagnostics and clinical testing
NextCure
All not exited/Clinical-stage biotech discovering and developing first-in-class immunotherapy-based biologics for cancer and other diseases
Oricell
All not exited/Leading China biotech of cell therapy with breakthrough in solid tumor
Rarestone Group
All not exited/Late clinical-stage biotech with an integrated platform for the development and commercialization of rare disease medicines in China
Sail Biomedicines
All not exited/Harnesses the power of first-in-category programmable payloads of eRNA, nanoparticles, and emerging, proprietary AI technologies, to unlock the comprehensive programming of medicines
Silexon
All not exited/Emerging AI-empowered technology company in China, leveraging unique algorithms to facilitate data-driven life science research
Syros
All not exited/First-in-class clinical pipeline targeting gene control in oncology
Tempest
All not exited/Clinical-stage biotech focusing on Immune-related pathways in oncology
Therorna
All not exited/Leading Chinese biotech focusing on next-generation RNA technology with global potential in multiple disease areas
Walking Fish
All not exited/Biotechnology company with leading B cell platform and broad pipeline addressing multiple diseases
Zenas BioPharma
All not exited/Clinical-stage biotech developing immune-based therapies for the world
Zidan
All not exited/Innovative minimal invasive medtech for early-stage lung cancer treatment
Exited
ARMO Biosciences
All exited/Late clinical-stage immuno-oncology biotech with novel, proprietary pipeline
dMed
All exited/Leading Chinese specialty clinical development CRO that serves local and global biotech/pharma clients
